My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 193

    1.

    Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone.

    Gold SM, Chalifoux S, Giesser BS, Voskuhl RR.

    J Neuroinflammation. 2008 Jul 31;5:32.PMID: 18671877 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of glatiramer acetate (Copaxone) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: a longitudinal study.

    Blanco Y, Moral EA, Costa M, Gómez-Choco M, Torres-Peraza JF, Alonso-Magdalena L, Alberch J, Jaraquemada D, Arbizu T, Graus F, Saiz A.

    Neurosci Lett. 2006 Oct 9;406(3):270-5. Epub 2006 Aug 24.PMID: 16934924 [PubMed - indexed for MEDLINE]Related articles

    3.

    Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.

    Sarchielli P, Zaffaroni M, Floridi A, Greco L, Candeliere A, Mattioni A, Tenaglia S, Di Filippo M, Calabresi P.

    Mult Scler. 2007 Apr;13(3):313-31. Epub 2007 Jan 29.PMID: 17439900 [PubMed - indexed for MEDLINE]Related articles

    4.

    Helminth infections associated with multiple sclerosis induce regulatory B cells.

    Correale J, Farez M, Razzitte G.

    Ann Neurol. 2008 Aug;64(2):187-99.PMID: 18655096 [PubMed - indexed for MEDLINE]Related articles

    5.

    Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.

    Hamamcioglu K, Reder AT.

    Mult Scler. 2007 May;13(4):459-70. Epub 2007 Feb 9.PMID: 17463069 [PubMed - indexed for MEDLINE]Related articles

    6.

    Modulation of antigenic phenotype in cultured human osteoblast-like cells by FGFb, TGFbeta1, PDGF-BB, IL-2, IL-1beta, LPS and IFNgamma.

    Pérez E, García-Martínez O, Arroyo-Morales M, Reyes-Botella C, Ruiz C.

    Biosci Rep. 2006 Aug;26(4):281-9.PMID: 17029006 [PubMed - indexed for MEDLINE]Related articles

    7.

    Angiocidin promotes pro-inflammatory cytokine production and antigen presentation in multiple sclerosis.

    Kremlev SG, Gaurnier-Hausser AL, Del Valle L, Perez-Liz G, Dimitrov S, Tuszynski G.

    J Neuroimmunol. 2008 Feb;194(1-2):132-42. Epub 2008 Jan 22.PMID: 18207252 [PubMed - indexed for MEDLINE]Related articles

    8.

    Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination.

    Linker R, Gold R, Luhder F.

    Crit Rev Immunol. 2009;29(1):43-68. Review.PMID: 19348610 [PubMed - indexed for MEDLINE]Related articles

    9.

    In vivo effects of mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients.

    Angelucci F, Batocchi AP, Caggiula M, Frisullo G, Patanella K, Sancricca C, Nociti V, Tonali PA, Mirabella M.

    Neuroimmunomodulation. 2006;13(2):76-81. Epub 2006 Sep 13.PMID: 16974110 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.

    Desai F, Ramanathan M, Fink CS, Wilding GE, Weinstock-Guttman B, Awad AB.

    Int Immunopharmacol. 2009 Jan;9(1):153-7. Epub 2008 Nov 18.PMID: 19022404 [PubMed - indexed for MEDLINE]Related articles

    11.

    Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.

    Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.

    Eur J Immunol. 2009 Sep;39(9):2525-36.PMID: 19670379 [PubMed - indexed for MEDLINE]Related articles

    12.

    Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor.

    Chen M, Valenzuela RM, Dhib-Jalbut S.

    J Neurol Sci. 2003 Nov 15;215(1-2):37-44.PMID: 14568126 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines.

    Vogelgesang A, Rosenberg S, Skrzipek S, Bröker BM, Dressel A.

    Acta Neurol Scand. 2009 Nov 19. [Epub ahead of print]PMID: 19925529 [PubMed - as supplied by publisher]Related articles

    14.

    Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.

    Lalive PH, Kantengwa S, Benkhoucha M, Juillard C, Chofflon M.

    J Neuroimmunol. 2008 Jul 15;197(2):147-51. Epub 2008 Jun 13.PMID: 18555540 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.

    Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH.

    Clin Immunol. 2008 Oct;129(1):80-9. Epub 2008 Jul 23.PMID: 18653385 [PubMed - indexed for MEDLINE]Related articles

    16.

    Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.

    Azoulay D, Mausner-Fainberg K, Urshansky N, Fahoum F, Karni A.

    J Neuroimmunol. 2009 Jun 25;211(1-2):114-9. Epub 2009 May 5.PMID: 19419774 [PubMed - indexed for MEDLINE]Related articles

    17.

    Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.

    Biernacki K, Antel JP, Blain M, Narayanan S, Arnold DL, Prat A.

    Arch Neurol. 2005 Apr;62(4):563-8.PMID: 15824253 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Methylthioadenosine reverses brain autoimmune disease.

    Moreno B, Hevia H, Santamaria M, Sepulcre J, Muñoz J, García-Trevijano ER, Berasain C, Corrales FJ, Avila MA, Villoslada P.

    Ann Neurol. 2006 Sep;60(3):323-34.PMID: 16786535 [PubMed - indexed for MEDLINE]Related articles

    19.

    Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.

    Oh U, Blevins G, Griffith C, Richert N, Maric D, Lee CR, McFarland H, Jacobson S.

    Arch Neurol. 2009 Apr;66(4):471-9.PMID: 19364932 [PubMed - indexed for MEDLINE]Related articles

    20.

    Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.

    Corrales JJ, Almeida M, Burgo R, Mories MT, Miralles JM, Orfao A.

    J Endocrinol. 2006 Jun;189(3):595-604.PMID: 16731790 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk